CGEN-40

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCGEN-40
Drug Alias NameCD40L trap (Compugen)CD40 soluble splice variant (Compugen)CGEN-40
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 inhibitors
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompugen Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A